UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022388
Receipt number R000025801
Scientific Title Randomized prospective study related to errors in the prediction of postoperative refraction following intraocular lens implantation with exfoliation syndrome
Date of disclosure of the study information 2016/06/01
Last modified on 2020/12/08 10:50:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized prospective study related to errors in the prediction of postoperative refraction following intraocular lens implantation with exfoliation syndrome

Acronym

Randomized prospective study related to errors in the prediction of postoperative refraction following intraocular lens implantation with exfoliation syndrome

Scientific Title

Randomized prospective study related to errors in the prediction of postoperative refraction following intraocular lens implantation with exfoliation syndrome

Scientific Title:Acronym

Randomized prospective study related to errors in the prediction of postoperative refraction following intraocular lens implantation with exfoliation syndrome

Region

Japan


Condition

Condition

exfoliation syndrome, cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To consider the refractive error between one-piece intraocular lens and three-piece intraocular lens in patients following cataract surgery accompanied by exfoliation syndrome

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

postoperative refractive error between one-piece intraocular lens and three-piece intraocular lens

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Patients with exfoliation syndrome undergo cataract surgery and are implanted one-piece intraocular lens.

Interventions/Control_2

Patients with exfoliation syndrome undergo cataract surgery and are implanted three-piece intraocular lens.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient who obtained the consent of the free will of the patient himself for this clinical research.
For patients with dementia, we get the consent from alternate (consort, children, grandson, brother, sister).

Key exclusion criteria

patients who underwent eye surgery previously
patients who deemed inappropriate by attending physician

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Nobuyuki
Middle name
Last name Ishikawa

Organization

Wakayama Medical University

Division name

Department of Ophthalmology

Zip code

6410012

Address

811-1 Kimiidera, Wakayama

TEL

073-447-2300

Email

niskw@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Nobuyuki
Middle name
Last name Ishikawa

Organization

Wakayama Medical University

Division name

Department of Ophthalmology

Zip code

6410012

Address

811-1 Kimiidera, Wakayama

TEL

073-447-2300

Homepage URL


Email

niskw@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical University

Institute

Department

Personal name



Funding Source

Organization

Wakayama Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Wakayama Medical University

Address

811-1 Kimiidera, Wakayama

Tel

073-447-2300

Email

wa-rinri@wakayama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 03 Month 01 Day

Date of IRB

2014 Year 10 Month 14 Day

Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date

2018 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 05 Month 20 Day

Last modified on

2020 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025801


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name